Review





Similar Products

96
Proteintech 1 ap cdk1 cell signaling
1 Ap Cdk1 Cell Signaling, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cdk1/Cyclin+B1+Antibody/pm42845052-252-19-26
Average 96 stars, based on 1 article reviews
1 ap cdk1 cell signaling - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech anti cdk6
Anti Cdk6, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cdk1/CDK1+Antibody/pm42815951-205-17-18
Average 96 stars, based on 1 article reviews
anti cdk6 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Boster Bio anti cdk1
Anti Cdk1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cdk1/Anti-CDK1+Antibody/pmc13656039-162-27-30
Average 94 stars, based on 1 article reviews
anti cdk1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Proteintech cdk1
Cdk1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cdk1/CDK1-Specific+Antibody/10__1186_slash_s12967___026___08792___w-74-48-49
Average 96 stars, based on 1 article reviews
cdk1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech anti cdk1
Anti Cdk1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cdk1/CDK1-Specific+Antibody/10__1186_slash_s12951___026___04871___8-199-7-10
Average 96 stars, based on 1 article reviews
anti cdk1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
ABclonal Biotechnology cdk1
The cell‐penetrating peptide TAT enhances the intracellular delivery and anti‐tumor activity of TAB12. (A) Representative images of the cellular uptake assay. MCF7 and CNE2 cells were incubated with 30 µ m FITC‐labeled TAB12 or TAT‐TAB12 peptide for 2 h. Cellular uptake of TAB12 and TAT‐TAB12 was observed by fluorescence microscopy. Cell nuclei were stained with DAPI. Scale bar, 10 µm. (B) In vitro serum stability of TAB12 and TAT‐TAB12 over time. (C) The impact of 80 µ m TAB12 or its TAT‐modified peptide TAT‐TAB12 on cell proliferation was assessed using the CCK‐8 assay ( n = 5). (D) The influence of 80 µ m TAB12 or TAT‐TAB12 treatment on colony‐forming ability was examined using the colony formation assay ( n = 3). (E) The effects of 80 µ m TAT or TAT‐TAB12 on cell migration were analyzed using the wound‐healing assay ( n = 3). (F) The influence of 80 µ m TAT or TAT‐TAB12 treatment on cell invasive ability was detected by the transwell assay ( n = 3). (G) In cells treated with 40 µ m TAT or TAT‐TAB12, the expression levels of BRD7, ZO‐1, N‐cadherin, Vimentin, <t>CDK1,</t> and CDK4 proteins were detected by Western blot. The data in (B,C,D,E,F) are presented as mean ± SD ( n ≥ 3). **, p < 0.01; ***, p < 0.001; ns, no significance.
Cdk1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cdk1/CDK1+Rabbit+mAb/pmc13440194-236-39-40
Average 94 stars, based on 1 article reviews
cdk1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Huabio Inc anti cdk1
The cell‐penetrating peptide TAT enhances the intracellular delivery and anti‐tumor activity of TAB12. (A) Representative images of the cellular uptake assay. MCF7 and CNE2 cells were incubated with 30 µ m FITC‐labeled TAB12 or TAT‐TAB12 peptide for 2 h. Cellular uptake of TAB12 and TAT‐TAB12 was observed by fluorescence microscopy. Cell nuclei were stained with DAPI. Scale bar, 10 µm. (B) In vitro serum stability of TAB12 and TAT‐TAB12 over time. (C) The impact of 80 µ m TAB12 or its TAT‐modified peptide TAT‐TAB12 on cell proliferation was assessed using the CCK‐8 assay ( n = 5). (D) The influence of 80 µ m TAB12 or TAT‐TAB12 treatment on colony‐forming ability was examined using the colony formation assay ( n = 3). (E) The effects of 80 µ m TAT or TAT‐TAB12 on cell migration were analyzed using the wound‐healing assay ( n = 3). (F) The influence of 80 µ m TAT or TAT‐TAB12 treatment on cell invasive ability was detected by the transwell assay ( n = 3). (G) In cells treated with 40 µ m TAT or TAT‐TAB12, the expression levels of BRD7, ZO‐1, N‐cadherin, Vimentin, <t>CDK1,</t> and CDK4 proteins were detected by Western blot. The data in (B,C,D,E,F) are presented as mean ± SD ( n ≥ 3). **, p < 0.01; ***, p < 0.001; ns, no significance.
Anti Cdk1, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cdk1/3+anti+caspase/pm42271454-70-28-32
Average 86 stars, based on 1 article reviews
anti cdk1 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Huabio Inc cdk1
The cell‐penetrating peptide TAT enhances the intracellular delivery and anti‐tumor activity of TAB12. (A) Representative images of the cellular uptake assay. MCF7 and CNE2 cells were incubated with 30 µ m FITC‐labeled TAB12 or TAT‐TAB12 peptide for 2 h. Cellular uptake of TAB12 and TAT‐TAB12 was observed by fluorescence microscopy. Cell nuclei were stained with DAPI. Scale bar, 10 µm. (B) In vitro serum stability of TAB12 and TAT‐TAB12 over time. (C) The impact of 80 µ m TAB12 or its TAT‐modified peptide TAT‐TAB12 on cell proliferation was assessed using the CCK‐8 assay ( n = 5). (D) The influence of 80 µ m TAB12 or TAT‐TAB12 treatment on colony‐forming ability was examined using the colony formation assay ( n = 3). (E) The effects of 80 µ m TAT or TAT‐TAB12 on cell migration were analyzed using the wound‐healing assay ( n = 3). (F) The influence of 80 µ m TAT or TAT‐TAB12 treatment on cell invasive ability was detected by the transwell assay ( n = 3). (G) In cells treated with 40 µ m TAT or TAT‐TAB12, the expression levels of BRD7, ZO‐1, N‐cadherin, Vimentin, <t>CDK1,</t> and CDK4 proteins were detected by Western blot. The data in (B,C,D,E,F) are presented as mean ± SD ( n ≥ 3). **, p < 0.01; ***, p < 0.001; ns, no significance.
Cdk1, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cdk1/3+anti+caspase/pm42212883-117-6-8
Average 86 stars, based on 1 article reviews
cdk1 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Huabio Inc anti phospho cdk1 thr161 antibody
Aluminum exposure induces G2/M phase arrest in mouse zygotes (A) Representative images of γ-H2A.X in zygotes from the control group and the AlCl 3 -treated group by immunofluorescence staining. Green, γ-H2A.X; blue, DNA. Scale bars, 20 μm. (B) Relative fluorescence intensity of γ-H2A.X. Control, n = 40; AlCl 3 , n = 41; ∗∗ p < 0.005. (C) Expression level and statistical analysis of RAD51 protein in zygotes of the control group and AlCl 3 -treated group by western blot. ∗∗∗∗ p < 0.0001. (D) The mRNA expression levels of DNA damage-related genes were significantly downregulated in the treatment group compared with the control by RT-qPCR. ∗∗∗ p < 0.0005, ∗∗∗ p < 0.0005, ∗∗∗∗ p < 0.0001. (E) Representative fluorescence images of CHK1 signals in zygotes of the control group and AlCl 3 -treated group by immunofluorescence staining. Green, CHK1; blue, DNA. Scale bars, 20 μm. (F) Relative fluorescence intensity of CHK1. Control, n = 34; AlCl 3 , n = 33; ∗∗ p < 0.005. (G) Expression level and statistical analysis of CDC25C protein in zygotes of the control group and AlCl 3 -treated group by western blot. ∗∗∗ p < 0.001. (H) Expression level and statistical analysis of Cyclin B1 protein in zygotes of the control group and AlCl 3 -treated group by western blot. ∗∗ p < 0.01. (I) Expression level and statistical analysis of p <t>-CDK1(T161)</t> protein in zygotes of the control group and AlCl 3 -treated group by western blot. ∗∗ p < 0.005. (J) The mRNA expression of cell cycle regulatory genes by RT-qPCR. ∗∗∗ p < 0.001, ∗∗ p < 0.005, ∗∗ p < 0.005, ∗ p < 0.05. Data are presented as mean ± SEM. All experiments were performed in three independent biological replicates, with three technical replicates per biological replicate; mouse zygotes were used as research subjects. n represents the number of zygotes analyzed. Statistical analysis was performed using paired t tests. Asterisks indicate statistical significance: ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
Anti Phospho Cdk1 Thr161 Antibody, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cdk1/3+anti+caspase/pmc13157191-12-0-4
Average 86 stars, based on 1 article reviews
anti phospho cdk1 thr161 antibody - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


The cell‐penetrating peptide TAT enhances the intracellular delivery and anti‐tumor activity of TAB12. (A) Representative images of the cellular uptake assay. MCF7 and CNE2 cells were incubated with 30 µ m FITC‐labeled TAB12 or TAT‐TAB12 peptide for 2 h. Cellular uptake of TAB12 and TAT‐TAB12 was observed by fluorescence microscopy. Cell nuclei were stained with DAPI. Scale bar, 10 µm. (B) In vitro serum stability of TAB12 and TAT‐TAB12 over time. (C) The impact of 80 µ m TAB12 or its TAT‐modified peptide TAT‐TAB12 on cell proliferation was assessed using the CCK‐8 assay ( n = 5). (D) The influence of 80 µ m TAB12 or TAT‐TAB12 treatment on colony‐forming ability was examined using the colony formation assay ( n = 3). (E) The effects of 80 µ m TAT or TAT‐TAB12 on cell migration were analyzed using the wound‐healing assay ( n = 3). (F) The influence of 80 µ m TAT or TAT‐TAB12 treatment on cell invasive ability was detected by the transwell assay ( n = 3). (G) In cells treated with 40 µ m TAT or TAT‐TAB12, the expression levels of BRD7, ZO‐1, N‐cadherin, Vimentin, CDK1, and CDK4 proteins were detected by Western blot. The data in (B,C,D,E,F) are presented as mean ± SD ( n ≥ 3). **, p < 0.01; ***, p < 0.001; ns, no significance.

Journal: Advanced Science

Article Title: TRIM28‐Derived Peptide Exerts Anti‐Tumor Roles by Stabilizing Tumor Suppressive BRD7 Protein in Multiple Cancers

doi: 10.1002/advs.76974

Figure Lengend Snippet: The cell‐penetrating peptide TAT enhances the intracellular delivery and anti‐tumor activity of TAB12. (A) Representative images of the cellular uptake assay. MCF7 and CNE2 cells were incubated with 30 µ m FITC‐labeled TAB12 or TAT‐TAB12 peptide for 2 h. Cellular uptake of TAB12 and TAT‐TAB12 was observed by fluorescence microscopy. Cell nuclei were stained with DAPI. Scale bar, 10 µm. (B) In vitro serum stability of TAB12 and TAT‐TAB12 over time. (C) The impact of 80 µ m TAB12 or its TAT‐modified peptide TAT‐TAB12 on cell proliferation was assessed using the CCK‐8 assay ( n = 5). (D) The influence of 80 µ m TAB12 or TAT‐TAB12 treatment on colony‐forming ability was examined using the colony formation assay ( n = 3). (E) The effects of 80 µ m TAT or TAT‐TAB12 on cell migration were analyzed using the wound‐healing assay ( n = 3). (F) The influence of 80 µ m TAT or TAT‐TAB12 treatment on cell invasive ability was detected by the transwell assay ( n = 3). (G) In cells treated with 40 µ m TAT or TAT‐TAB12, the expression levels of BRD7, ZO‐1, N‐cadherin, Vimentin, CDK1, and CDK4 proteins were detected by Western blot. The data in (B,C,D,E,F) are presented as mean ± SD ( n ≥ 3). **, p < 0.01; ***, p < 0.001; ns, no significance.

Article Snippet: Primary antibodies: BRD7 (Proteintech, #51009‐2‐AP, 1:3000); TRIM28 (Proteintech, #15202‐1‐AP, 1:3000); GAPDH (Proteintech, #10494‐1‐AP, 1:10000); Flag (Sigma, #F2555, 1:500); HA (MBL, #M132‐3, 1:1000); Ub (Santa Cruz, #sc‐8017, 1:1000); ZO‐1 (Proteintech, #21773‐1‐AP, 1:1000); Vimentin (Abcam, #EPR3776, 1:1000); N‐cadherin (Proteintech, #22018‐1‐AP, 1:1000); CDK1 (Abclonal, #A11420, 1:1000); CDK4 (Abclonal, #A23522, 1:1000); TRIM25 (Abclonal, #A12938, 1:2000); Rb (Abclonal, # A28031 , 1:5000); p53 (Proteintech, #10442‐1‐AP, 1:2000); p27 (Affinity, #AF6324, 1:1000); Total‐PARP (Affinity, #DF7198, 1:1000); and Cleaved‐PARP (Affinity, #AF7023, 1:1000).

Techniques: Activity Assay, Incubation, Labeling, Fluorescence, Microscopy, Staining, In Vitro, Modification, CCK-8 Assay, Colony Assay, Migration, Wound Healing Assay, Transwell Assay, Expressing, Western Blot

Aluminum exposure induces G2/M phase arrest in mouse zygotes (A) Representative images of γ-H2A.X in zygotes from the control group and the AlCl 3 -treated group by immunofluorescence staining. Green, γ-H2A.X; blue, DNA. Scale bars, 20 μm. (B) Relative fluorescence intensity of γ-H2A.X. Control, n = 40; AlCl 3 , n = 41; ∗∗ p < 0.005. (C) Expression level and statistical analysis of RAD51 protein in zygotes of the control group and AlCl 3 -treated group by western blot. ∗∗∗∗ p < 0.0001. (D) The mRNA expression levels of DNA damage-related genes were significantly downregulated in the treatment group compared with the control by RT-qPCR. ∗∗∗ p < 0.0005, ∗∗∗ p < 0.0005, ∗∗∗∗ p < 0.0001. (E) Representative fluorescence images of CHK1 signals in zygotes of the control group and AlCl 3 -treated group by immunofluorescence staining. Green, CHK1; blue, DNA. Scale bars, 20 μm. (F) Relative fluorescence intensity of CHK1. Control, n = 34; AlCl 3 , n = 33; ∗∗ p < 0.005. (G) Expression level and statistical analysis of CDC25C protein in zygotes of the control group and AlCl 3 -treated group by western blot. ∗∗∗ p < 0.001. (H) Expression level and statistical analysis of Cyclin B1 protein in zygotes of the control group and AlCl 3 -treated group by western blot. ∗∗ p < 0.01. (I) Expression level and statistical analysis of p -CDK1(T161) protein in zygotes of the control group and AlCl 3 -treated group by western blot. ∗∗ p < 0.005. (J) The mRNA expression of cell cycle regulatory genes by RT-qPCR. ∗∗∗ p < 0.001, ∗∗ p < 0.005, ∗∗ p < 0.005, ∗ p < 0.05. Data are presented as mean ± SEM. All experiments were performed in three independent biological replicates, with three technical replicates per biological replicate; mouse zygotes were used as research subjects. n represents the number of zygotes analyzed. Statistical analysis was performed using paired t tests. Asterisks indicate statistical significance: ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Journal: iScience

Article Title: Aluminum exposure impairs nuclear envelope breakdown for mouse zygote formation

doi: 10.1016/j.isci.2026.115807

Figure Lengend Snippet: Aluminum exposure induces G2/M phase arrest in mouse zygotes (A) Representative images of γ-H2A.X in zygotes from the control group and the AlCl 3 -treated group by immunofluorescence staining. Green, γ-H2A.X; blue, DNA. Scale bars, 20 μm. (B) Relative fluorescence intensity of γ-H2A.X. Control, n = 40; AlCl 3 , n = 41; ∗∗ p < 0.005. (C) Expression level and statistical analysis of RAD51 protein in zygotes of the control group and AlCl 3 -treated group by western blot. ∗∗∗∗ p < 0.0001. (D) The mRNA expression levels of DNA damage-related genes were significantly downregulated in the treatment group compared with the control by RT-qPCR. ∗∗∗ p < 0.0005, ∗∗∗ p < 0.0005, ∗∗∗∗ p < 0.0001. (E) Representative fluorescence images of CHK1 signals in zygotes of the control group and AlCl 3 -treated group by immunofluorescence staining. Green, CHK1; blue, DNA. Scale bars, 20 μm. (F) Relative fluorescence intensity of CHK1. Control, n = 34; AlCl 3 , n = 33; ∗∗ p < 0.005. (G) Expression level and statistical analysis of CDC25C protein in zygotes of the control group and AlCl 3 -treated group by western blot. ∗∗∗ p < 0.001. (H) Expression level and statistical analysis of Cyclin B1 protein in zygotes of the control group and AlCl 3 -treated group by western blot. ∗∗ p < 0.01. (I) Expression level and statistical analysis of p -CDK1(T161) protein in zygotes of the control group and AlCl 3 -treated group by western blot. ∗∗ p < 0.005. (J) The mRNA expression of cell cycle regulatory genes by RT-qPCR. ∗∗∗ p < 0.001, ∗∗ p < 0.005, ∗∗ p < 0.005, ∗ p < 0.05. Data are presented as mean ± SEM. All experiments were performed in three independent biological replicates, with three technical replicates per biological replicate; mouse zygotes were used as research subjects. n represents the number of zygotes analyzed. Statistical analysis was performed using paired t tests. Asterisks indicate statistical significance: ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Article Snippet: Anti-phospho-CDK1 (Thr161) antibody , HuaBio , Cat# HA721987; RRID: N/A.

Techniques: Control, Immunofluorescence, Staining, Fluorescence, Expressing, Western Blot, Quantitative RT-PCR